Systemic inflammation in nonischemic dilated cardiomyopathy

Heart and Vessels

Volumn 23, Issue 6, 2008, Pages 445-450

  De Gennaro, Luisa ^a   Brunetti, Natale Daniele ^a   Cuculo, Andrea ^a   Pellegrino, Pier Luigi ^a   Biase, Matteo ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Inflammation; New York Heart Association functional class; Nonischemic dilated cardiomyopathy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CORRELATION ANALYSIS; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; NONISCHEMIC CONGESTIVE CARDIOMYOPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTEMIC DISEASE; THORAX RADIOGRAPHY;

BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CARDIOMYOPATHY, DILATED; COLORIMETRY; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; RADIOGRAPHY, THORACIC; STROKE VOLUME;

EID: 57049138290     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1075-4     Document Type: Article

References (23)

1. Yin WH, Chen JW, Jen HL, Chiang MC, Huang WP, Feng AN, Young MS, Lin SJ (2004) Independent prognostic value of elevated high sensitivity C-reactive protein in chronic heart failure. Am Heart J 147:931-938
2. Sharma R, Rauchhaus M, Ponikowski PP, Varney S, Poole-Wilson PA, Mann DL, Coats AJS, Anker SD (2000) The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 6:523-528
3. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M (2003) Inflammatory markers and onset of cardiovascular events: Results from the Health ABC study. Circulation 108: 2317-2322
4. Sampietro T, Neglia D, Bionda A, Dal Pino B, Bigazzi F, Puntoni M, Startari U, Morales A, Minichilli F, Bianchi F, L'Abbate A (2005) Inflammatory markers and serum lipids in idiopathic dilated cardiomyopathy. Am J Cardiol 96:1718-1720
5. Kaneko K, Kanda T, Yamauchi Y, Hasegawa A, Iwasaki T, Arai M, Suzuki T, Kobayashi I, Nagai R (1999) C-reactive protein in dilated cardiomyopathy. Cardiology 91:215-219
6. Lamparter S, Grimm W (2005) Predictive value of high-sensitivity C-reactive protein in patients with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol. 28Suppl 1:S233-S236
7. Calabrò P, Willerson JT, Yeh ET (2003) Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108:1930-1932
8. Gould JM, Weiser JN (2001) Expression of C-reactive protein in the human respiratory tract. Infect Immun 69:1747-1748
9. Jabs WJ, Logering BA, Gerke P, Kreft B, Wolber EM, Klinger MH, Fricke L, Steinhoff J (2003) The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol 33:152-161
10. Yasojima K, Schwab C, McGeer EG, McGeer PL (2000) Human neurons generate C-reactive protein and amyloid P: Upregulation in Alzheimer's disease. Brain Res 887:80-89
11. Nijmeijer R, Lagrand WK, Lubbers YT, Visser CA, Meijer CJ, Niessen HW, Hack CE (2003) C-reactive protein activates complement in infarcted human myocardium. Am J Pathol 163:269-275
12. Satoh M, Nakamura M, Akatsu T, Shimoda Y, Segawa I, Hiramori K (2005) C-reactive protein co-expresses with tumor necrosis factor-alpha in the myocardium in human dilated cardiomyopathy. Eur J Heart Fail 7:748-754
13. Ikeda U, Maeda Y, Yamamoto K, Shimada K (2002) C-reactive protein augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. Cardiovasc Res 56:86-92
14. Pasceri V, Chang J, Willerson JT, Yeh ETH (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103:2531-2534
15. Choi H, Cho DH, Shin HH, Park JB (2004) Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. Circ J 68:628-633
16. Ishikawa C, Tsutamoto T, Fujii M, Sakai H, Tanaka T, Horie M (2006) Prediction of mortality by high-sensitivity C-reactive protein and brain natriuretic peptide in patients with dilated cardiomyopathy. Circ J 70:857-863
17. Fukunaga T, Soejima H, Irie A, Sugamura K, Oe Y, Tanaka T, Nagayoshi Y, Kaikita K, Sugiyama S, Yoshimura M, Nishimura Y, Ogawa H (2007) Relation between CD4+ T-cell activation and severity of chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 100:483-488
18. Fukunaga T, Soejima H, Irie A, Sugamura K, Oe Y, Tanaka T, Kojima S, Sakamoto T, Yoshimura M, Nishimura Y, Ogawa H (2007) Expression of interferon-gamma and interleukin-4 production in CD4+ T cells in patients with chronic heart failure. Heart Vessels 22:178-183
19. Sánchez-Lázaro IJ, Almenar L, Reganon E, Vila V, Martínez-Dolz L, Martínez-Sales V, Moro J, Agüero J, Ortiz-Martínez V, Salvador A (2007) Inflammatory markers in stable heart failure and their relationship with functional class. Int J Cardiol [Epub ahead of print]
20. Abou-Raya S, Abou-Raya A, Naim A, Abuelkheir H (2007) Chronic inflammatory autoimmune disorders and atherosclerosis. Ann N Y Acad Sci 1107:56-67
21. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S (1989) Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 14: 564-570
22. Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KS, Banerjee A, Harken AH (1999) Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med 27:1309-1318
23. Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M, Kinoshita M (1998) Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 31:391-398